Satisfai Health receives co-investment from DIGITAL, Canada’s Global Innovation Cluster for digital technologies, for the development of its AI solution for Intestinal Ultrasound, Sonai, in Inflammatory Bowel Disease (TheNewswire)

Satisfai Health Inc., in collaboration with several partners including Alimentiv and Canadian universities, is receiving co-investment from DIGITAL to develop AI tools for Intestinal Ultrasound (IUS) in managing Inflammatory Bowel Disease (IBD). This AI tool, named Sonai, aims to improve the accuracy and accessibility of IUS, a non-invasive and cost-effective method used to assess IBD treatment responses. The initiative, supported by DIGITAL, is poised to enhance the application of AI in healthcare and revolutionize IBD management.